Company Information

Company Novartis de Colombia
www.novartis.com.co
Type:
Company
Country:
Colombia
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
25 January 2005
Next Communication on Progress (COP) due on:
31 July 2024

Early Adopter

Enhanced Communication on Progress

Communication On Progress

Published On Title Level/Status
30-Jun-2022 2022 Communication on Progress Submitted
24-Nov-2021 Communication on Progress Active
26-Nov-2020 Communication on Progress Active
26-Nov-2020 Corporate Responsibility Report Learner
22-Sep-2019 Grace Letter Not applicable
22-Sep-2018 Communication on Progress Learner
22-Jun-2018 Grace Letter Not applicable
24-Jun-2017 Communication on Progress Active
25-Mar-2017 Grace Letter Not applicable
25-Mar-2016 Communication on Progress Active
22-Dec-2015 Grace Letter Not applicable
26-Dec-2014 Communication on Progress Active
26-Sep-2014 Grace Letter Not applicable
27-Sep-2013 2013 Novartis de Colombia Communication on Progress Active
27-Sep-2012 Novartis de Colombia - Communication on Progress Active
28-Jun-2012 Grace Letter Not applicable
29-Jun-2011 2011 Communication on Progress Active
30-Mar-2011 Grace Letter Not applicable
30-Mar-2009 2008 Global Compact Report Novartis Colombia Not applicable
02-Mar-2009 Grace Period Letter Not applicable
03-Mar-2008 Colombia Global Compact Report Not applicable
01-Mar-2007 UNGC CoP Novartis Colombia Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.